Bar Harbor Bankshares (BHB) director acquires shares via DRIP at $32.66
Rhea-AI Filing Summary
Brian D. Shaw, a director of Bar Harbor Bankshares (BHB), reported a purchase of 26.725 shares of the issuer's common stock on 09/12/2025 at a price of $32.66 per share. The filing shows these shares were acquired through the company's Dividend Reinvestment and Direct Stock Purchase and Sale Plan and that the transaction is exempt under Rule 16b-3(d). Following the transaction, the reporting person is shown as beneficially owning 17,490.27 shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025. The filing contains no additional compensatory or derivative transactions.
Positive
- Director participation in DRIP signals alignment with shareholder-focused compensation mechanisms
- Transaction reported under Rule 16b-3(d), indicating it arose from an approved company plan
- Complete disclosure of transaction date, share count, and price consistent with Section 16 reporting
Negative
- None.
Insights
TL;DR: Small, routine DRIP purchase by a director; not material to company valuation.
The reported acquisition of 26.725 shares at $32.66 via the Dividend Reinvestment and Direct Stock Purchase Plan is a routine insider purchase that increases the director's stake to 17,490.27 shares. This transaction is disclosed as exempt under Rule 16b-3(d), indicating it stems from an established company plan rather than an opportunistic market trade. The absolute size of the purchase is small relative to typical institutional holdings and does not reflect any disclosed change in compensation, control, or debt structure. For investors, this is a housekeeping disclosure consistent with insider participation in company plans.
TL;DR: Compliance-focused filing showing plan participation; supports governance transparency.
The Form 4 documents compliance with Section 16 reporting by a director who acquired shares through the issuer's shareholder plan. Listing the Rule 16b-3(d) exemption clarifies the acquisition was part of an approved plan, reducing concerns about self-dealing or timing. The filing is properly signed by an attorney-in-fact and includes the required transaction details: date, share count, and price. No derivative instruments or amendments are indicated. This is a standard governance disclosure, demonstrating adherence to reporting obligations.
FAQ
What transaction did BHB director Brian D. Shaw report on Form 4?
How many shares does Brian D. Shaw beneficially own after the reported transaction?
Why was the transaction exempt under Rule 16b-3(d)?
When was the Form 4 signed and filed for this transaction?
Does the Form 4 report any derivative transactions or amendments?